Iftikhar Muhammad, Saqib Muhammad, Qayyum Sardar Noman, Asmat Rehana, Mumtaz Hassan, Rehan Muhammad, Ullah Irfan, Ud-Din Iftikhar, Noori Samim, Khan Maleeka, Rehman Ehtisham, Ejaz Zain
Khyber Medical College, Peshawar.
Bacha Khan Medical College, Mardan.
Ann Med Surg (Lond). 2024 Jul 23;86(9):5334-5342. doi: 10.1097/MS9.0000000000002369. eCollection 2024 Sep.
Artificial intelligence (AI) has been applied in healthcare for diagnosis, treatments, disease management, and for studying underlying mechanisms and disease complications in diseases like diabetes and metabolic disorders. This review is a comprehensive overview of various applications of AI in the healthcare system for managing diabetes. A literature search was conducted on PubMed to locate studies integrating AI in the diagnosis, treatment, management and prevention of diabetes. As diabetes is now considered a pandemic now so employing AI and machine learning approaches can be applied to limit diabetes in areas with higher prevalence. Machine learning algorithms can visualize big datasets, and make predictions. AI-powered mobile apps and the closed-loop system automated glucose monitoring and insulin delivery can lower the burden on insulin. AI can help identify disease markers and potential risk factors as well. While promising, AI's integration in the medical field is still challenging due to privacy, data security, bias, and transparency. Overall, AI's potential can be harnessed for better patient outcomes through personalized treatment.
人工智能(AI)已应用于医疗保健领域,用于诊断、治疗、疾病管理,以及研究糖尿病和代谢紊乱等疾病的潜在机制和疾病并发症。本综述全面概述了AI在糖尿病管理医疗系统中的各种应用。在PubMed上进行了文献检索,以查找将AI整合到糖尿病诊断、治疗、管理和预防中的研究。由于目前糖尿病被视为一种大流行病,因此采用AI和机器学习方法可应用于糖尿病患病率较高的地区,以限制糖尿病的发生。机器学习算法可以可视化大型数据集并进行预测。由AI驱动的移动应用程序以及闭环系统自动血糖监测和胰岛素输送可以减轻胰岛素负担。AI还可以帮助识别疾病标志物和潜在风险因素。尽管前景广阔,但由于隐私、数据安全、偏差和透明度等问题,AI在医学领域的整合仍然具有挑战性。总体而言,通过个性化治疗,可以利用AI的潜力来改善患者的治疗效果。